P-SUB product matrix combined with 0.2 µm pore SepraPor HFF

	CellRetention - series 30 TFF-Integrated P-SUB	CellMembra - series 31 ATF-SUBmerged P-SUB	CellRetention - series 32 ATF-Traditional P-SUB	CellRetention - series 33 ATF-SUBmerged kit
Sizes / Products	TFF - series 30	ATF - series 31	ATF - series 32	ATF - series 33
HFF/SUP kit PG13 port	N	N	N	pn 33-0010
250 OD68 Modular	N	N	N	pn 33-0020
300 OD76 DASbox	pn 30-0031	pn 31-0031	pn 32-0031	N
500 OD82 CellVessel	pn 30-0050	pn 31-0050	N	N
2 – OD110	N	pn 31-0200	N	N
3 – OD137	pn 30-0320	pn 31-0320	pn 32-0320	pn 33-0021
6 – OD150	N	N	N	N
13 – OD200	pn 30-1301	pn 31-1301	pn 32-1301	N
30 – OD250	ultimo 2026	pn 31-3001	Y	N

The matrix describe what’s physical possible, presently available and originally designed for expression of mAbs. The numbers in first column refer to Vessel Volume in ml or liter. Numbers behind OD is available vessel diameter in mm.

Check actual delivery time and price under Commerce. All products are manufactured according to order with delivery time depending on product.

N and Y and non active pn numbers refer to either not currently available or not possible, active pn numbers can be ordered.

We agree in this website is both extensive and very informative. In order to make it easier to get around we have added numbers to folders which correspond with product groups and part numbers. 30 numbers are consumables, 40 numbers are equipment.

----------------------------------------    

Patents granted for CellMembra™, CerPhragm™, CellRetention™ and a range of patent applications belong to Stobbe Group. Patents and applications which gives PerfuseCell Freedom-to-Operate, eliminate infringement of others IPR and give freedom to our customers. 

Any perfusion products system with a pump and two or more HFFs separated by valves is covered by granted US patent owned by Stobbe Group.

You can check out status here.